Treatment of Bone Metastases of Breast Cancer With 177 Lu-DOTA-IBA

Clin Nucl Med. 2024 Jul 1;49(7):659-661. doi: 10.1097/RLU.0000000000005193. Epub 2024 Mar 25.

Abstract

Bone metastasis of breast cancer often presents as osteolytic. 177 Lu-DOTA-ibandronic acid ( 177 Lu-DOTA-IBA) is a new radioactive drug for bone metastasis lesion. We report a case of recurrent intermittent pain due to bone metastasis, who demonstrated a satisfactory therapy response after 2 cycles of 177 Lu-DOTA-IBA. In addition, the patient did not have any observable adverse effects.

Publication types

  • Case Reports

MeSH terms

  • Bone Neoplasms* / diagnostic imaging
  • Bone Neoplasms* / radiotherapy
  • Bone Neoplasms* / secondary
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Lutetium
  • Middle Aged
  • Organometallic Compounds

Substances

  • Lutetium
  • Organometallic Compounds